These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 31473342)

  • 1. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
    Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
    Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses.
    Baker LE; Ellena JF; Handing KB; Derewenda U; Utepbergenov D; Engel DA; Derewenda ZS
    Acta Crystallogr D Struct Biol; 2016 Jan; 72(Pt 1):49-58. PubMed ID: 26894534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system.
    Guito JC; Albariño CG; Chakrabarti AK; Towner JS
    Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
    Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
    Front Immunol; 2021; 12():703986. PubMed ID: 34484200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.
    Bixler SL; Bocan TM; Wells J; Wetzel KS; Van Tongeren SA; Dong L; Garza NL; Donnelly G; Cazares LH; Nuss J; Soloveva V; Koistinen KA; Welch L; Epstein C; Liang LF; Giesing D; Lenk R; Bavari S; Warren TK
    Antiviral Res; 2018 Mar; 151():97-104. PubMed ID: 29289666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, validation and clinical evaluation of a broad-range pan-filovirus RT-qPCR.
    Jääskeläinen AJ; Sironen T; Diagne CT; Diagne MM; Faye M; Faye O; Faye O; Hewson R; Mölsä M; Weidmann MW; Watson R; Sall AA; Vapalahti O
    J Clin Virol; 2019 May; 114():26-31. PubMed ID: 30904708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein.
    Changula K; Yoshida R; Noyori O; Marzi A; Miyamoto H; Ishijima M; Yokoyama A; Kajihara M; Feldmann H; Mweene AS; Takada A
    Virus Res; 2013 Sep; 176(1-2):83-90. PubMed ID: 23702199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    Callendret B; Vellinga J; Wunderlich K; Rodriguez A; Steigerwald R; Dirmeier U; Cheminay C; Volkmann A; Brasel T; Carrion R; Giavedoni LD; Patterson JL; Mire CE; Geisbert TW; Hooper JW; Weijtens M; Hartkoorn-Pasma J; Custers J; Grazia Pau M; Schuitemaker H; Zahn R
    PLoS One; 2018; 13(2):e0192312. PubMed ID: 29462200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations.
    Kuhn JH; Becker S; Ebihara H; Geisbert TW; Johnson KM; Kawaoka Y; Lipkin WI; Negredo AI; Netesov SV; Nichol ST; Palacios G; Peters CJ; Tenorio A; Volchkov VE; Jahrling PB
    Arch Virol; 2010 Dec; 155(12):2083-103. PubMed ID: 21046175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease.
    Brannan JM; Froude JW; Prugar LI; Bakken RR; Zak SE; Daye SP; Wilhelmsen CE; Dye JM
    J Infect Dis; 2015 Oct; 212 Suppl 2():S282-94. PubMed ID: 25943199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants.
    Shu Q; Kenny T; Fan J; Lyon CJ; Cazares LH; Hu TY
    PLoS Pathog; 2021 Nov; 17(11):e1010039. PubMed ID: 34748613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies.
    Rahim MN; Wang M; Wang T; He S; Griffin BD; Kobasa D; Yang R; Du Z; Qiu X
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30875741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.
    Warfield KL; Dye JM; Wells JB; Unfer RC; Holtsberg FW; Shulenin S; Vu H; Swenson DL; Bavari S; Aman MJ
    PLoS One; 2015; 10(3):e0118881. PubMed ID: 25793502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
    Woolsey C; Borisevich V; Agans KN; O'Toole R; Fenton KA; Harrison MB; Prasad AN; Deer DJ; Gerardi C; Morrison N; Cross RW; Eldridge JH; Matassov D; Geisbert TW
    J Infect Dis; 2023 Nov; 228(Suppl 7):S660-S670. PubMed ID: 37171813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT-1 Knockout Mice as a Model for Wild-Type Sudan Virus (SUDV).
    Escaffre O; Juelich TL; Neef N; Massey S; Smith J; Brasel T; Smith JK; Kalveram B; Zhang L; Perez D; Ikegami T; Freiberg AN; Comer JE
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
    Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis.
    Tambunan USF; Alkaff AH; Nasution MAF; Parikesit AA; Kerami D
    J Mol Graph Model; 2017 Jun; 74():366-378. PubMed ID: 28482272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.